LEUPROLIDE
Urinary Complications
University College, Londonprotein_peptidePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the Urinary Complications cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Rocuronium Rainer Lenhardt | Phase 4 | BB |
Zoladex University College, London | Phase 3 | BB |
Zoledronate Alliance for Clinical Trials in Oncology | Phase 3 | B |
Casodex University College, London | Phase 3 | B |
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Hans Bahlmann | Phase 3 | B |
View all 17 →
Same molecule, other indications
LEUPROLIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →